0001437749-20-005801.txt : 20200320 0001437749-20-005801.hdr.sgml : 20200320 20200320190100 ACCESSION NUMBER: 0001437749-20-005801 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191230 FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson Robert W. CENTRAL INDEX KEY: 0001432527 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38244 FILM NUMBER: 20733254 MAIL ADDRESS: STREET 1: 3001 MEANDERING RIVER COURT CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genprex, Inc. CENTRAL INDEX KEY: 0001595248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900772347 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 BUSINESS PHONE: 512-537-7997 MAIL ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2019-12-30 2020-01-02 0001595248 Genprex, Inc. GNPX 0001432527 Pearson Robert W. 1601 TRINITY STREET BLDG B, STE 3.322 AUSTIN TX 78712 1 Stock Option (Right to Buy) 1.45 2019-12-30 4 A 0 68376 0 A 2020-06-10 2029-12-30 Common Stock 68376 68376 D Equal to the fair market value of a share of common stock on June 10, 2019, the date on which the option grant was to be made under the Genprex, Inc. Outside Director Compensation Policy. One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 10, 2019 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date. This Form 4 amendment is being filed to reflect that on March 18, 2020, the Option was amended to provide that one hundred percent (100%) of the Shares subject to the Option became exercisable on March 18, 2020. /s/ Robert W. Pearson 2020-03-20